CCHR	Concurrent chemoradiation
CI	Confidence interval
C-Kit	Proto-oncogene C-Kit, a tyrosine kinase protein
CT	Computerised tomography
dVIN	Well-differentiated vulvar intraepithelial neoplasia
FIGO	International Federation of Gynaecology and Obstetrics
FNAB	Fine needle aspiration biopsy
Gy	Gray
HPV	Human papillomavirus
HR	Hazard ratio
ICI	Immune checkpoint inhibitors
IMRT	Intensity-modulated radiation therapy
LAVC	Locally advanced vulvar cancer
Mdm2	Murine double minute 2 gene
MRI	Magnetic resonance imaging
mTOR	Mammalian target of rapamycin
NACT	Neoadjuvant chemotherapy
E6/E7	HPV oncogenic proteins E6 and E7
EGFR	Epidermal growth factor receptor
p53	p53 tumour suppressor gene
PET	Positron emission tomography
PD-1	Programmed death-1
PD-L1	Programmed death-ligand 1
PD-L2	Programmed death-ligand 2
pRb	Rb tumour suppressor gene
RCT	Randomised controlled trial
SCC	Squamous cell carcinoma
SIL	Squamous intraepithelial lesion
TLR	Toll-like receptor
VEGF	Vascular endothelial growth factor
VHSIL	Vulvar high-grade squamous intraepithelial lesion
VMAT	Volumetric arc therapy
VSCC	Vulvar squamous cell carcinoma